I personally view the compassionate use of Rem-L for the 50 or...

I personally view the compassionate use of Rem-L for the 50 or so children with MIS-C as a regulatory tick of approval to administer a potential life-saving treatment to the small numbers of children affected, and not strictly as a trial per se (of course valuable data will be generated).

The EAP simply provides a legitimate means to treat children with MIS-C and potentially save lives. Without this EAP in place there would be no way of treating the children.

I imagine the potential numbers of children are small, let alone those [parents] willing or able to sign up to the treatment (due to location, urgency, hospital resources etc).

All that said, if it can save just one child's life it is fantastic, and a benefit for public opinion of stem cell therapy (the media will be all over this good news story).